Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Aquestive Therapeutics Inc (AQST)

5.26   -0.06 (-1.13%) 10-24 22:46
Open: 5.33 Pre. Close: 5.32
High: 5.38 Low: 5.1922
Volume: 289,302 Market Cap: 177M
Aquestive Therapeutics, Inc. is a specialty pharmaceutical company focused on identifying, developing, and commercializing differentiated products to address unmet medical needs. The company is headquartered in Warren, New Jersey and currently employs 277 full-time employees. The firm is focused on the development of treatments for diseases related to the central nervous system (CNS). Its CNS programs consist of a pipeline of products that include Libervant, Sympazan, and AQST-117. Libervant is a buccal soluble film formulation of diazepam for the treatment of recurrent epileptic seizures. Sympazan is an oral soluble film formulation of clobazam for the treatment of seizures associated with a rare, intractable form of epilepsy known as Lennox-Gastaut Syndrome. AQST-117 is an oral soluble film formulation of riluzole for the treatment of Amyotrophic Lateral Sclerosis. The Company’s complex molecule programs consist of AQST-108, and AQST-305, for the treatment of anaphylaxis and neuroendocrine tumors respectively. The firm also has a pipeline of products under partner programs, which includes Suboxone and APL-130277 for the treatment of opioid dependence, and Parkinson’s disease.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.387 - 5.413 5.413 - 5.439
Low: 5.114 - 5.146 5.146 - 5.178
Close: 5.199 - 5.251 5.251 - 5.302

Technical analysis

as of: 2020-10-23 4:40:40 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 8.52     One year: 10.62
Support: Support1: 4.38    Support2: 3.64
Resistance: Resistance1: 7.29    Resistance2: 9.09
Pivot: 5.00
Moving Average: MA(5): 5.29     MA(20): 4.93
MA(100): 6.01     MA(250): 5.18
MACD: MACD(12,26): -0.42     Signal(9): -0.55
Stochastic oscillator: %K(14,3): 72.68     %D(3): 75.95
RSI: RSI(14): 43.32
52-week: High: 10.00  Low: 1.41  Change(%): 27.7
Average Vol(K): 3-Month: 116741  10-Days: 62831

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
AQST has closed below upper band by 22.2%. Bollinger Bands are 59.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to AQST's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 19 Oct 2020
Aquestive Therapeutics, Inc. (NASDAQ:AQST): Is Breakeven Near? - Yahoo Finance

Wed, 14 Oct 2020
H.C. Wainwright slashes price target on Aquestive Therapeutics Inc. [AQST] – find out why. - The DBT News

Tue, 13 Oct 2020
How Does Aquestive Therapeutics Inc (AQST) Stock Rank on Wall Street? - InvestorsObserver

Mon, 12 Oct 2020
What Kind Of Shareholders Hold The Majority In Aquestive Therapeutics, Inc.’s (NASDAQ:AQST) Shares? - Simply Wall St

Fri, 02 Oct 2020
Is Aquestive Therapeutics Inc. (AQST) a Keeper? - The News Heater

Wed, 30 Sep 2020
Is Aquestive Therapeutics Inc (AQST) a Stock to Watch This Week? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Outperform Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 34
Shares Float (M) 28
% Held by Insiders 13.68
% Held by Institutions 57.50
Shares Short (K) 1,500
Shares Short P. Month (K) 1,750

Stock Financials

EPS -1.683
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) -0.640
Profit Margin -84.20
Operating Margin -57.99
Return on Assets (ttm) -37.7
Return on Equity (ttm)
Qtrly Rev. Growth 94.8
Gross Profit (p.s.) 0.959
Sales Per Share 1.763
EBITDA (p.s.) -0.927
Qtrly Earnings Growth
Operating Cash Flow (M) -49
Levered Free Cash Flow (M) -27

Stock Valuations

PE Ratio -3.13
PEG Ratio
Price to Book value -8.22
Price to Sales 2.98
Price to Cash Flow -3.61

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.